BlackRock »

Carmell Therapeutics Corp - US shares owned by BlackRock

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by BlackRock

Quarter filed Position value Share count Share price at filing
2024-03-31 $81k 32k 2.56
2023-09-30 $114k 32k 3.60

More positions owned by BlackRock

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)

View all positions for BlackRock

Top funds holding Carmell Therapeutics Corp - US

Meteora Capital
Vanguard Group
Carnegie Mellon University
Geode Capital Management
Northern Trust
BlackRock
XTX Topco
Hubbell Strickland Wealth Management
Morgan Stanley
Tower Research Capital
Royal Bank of Canada
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Carmell Therapeutics Corp - US